申请人:Li Hui
                            
                            
                                公开号:US20080194603A1
                            
                            
                                公开(公告)日:2008-08-14
                            
                            The invention encompasses compounds having formula I and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases are therapeutically useful.
                            本发明涵盖具有I式的化合物,以及使用这些化合物在调节JAK通路或抑制JAK激酶在治疗中具有治疗作用的情况下的组合物和方法。